Gene screening first for German health insurer
This article was originally published in Clinica
A German health insurance fund has become the first of its kind in the country to offer clients gene tests. The Kaufmannische Krankenkasse Hannover (KKH) is to provide screening for haemochromatosis, a hereditary disorder in which there is excessive absorption and storage of iron in the blood.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.